Items tagged with Scientific research
OVERDUE: Including pregnant participants in TB research - webinar materials now available online (post)
The SMART4TB Consortium hosted a webinar on 20 June 2024 about the consensus process and statement for earlier inclusion of pregnant women and persons in TB research. It featured advocates sharing their experiences with TB and pregnancy, and profiling SMART4TB studies that are responding to the call for inclusion.
Two new weapons in the battle against bacteria (post with simple image)
Proteases are vital proteins that serve for order within cells. They break apart other proteins, ensuring that these are properly synthesized and decomposed. Proteases are also responsible for the pathogenic effects of many kinds of bacteria. Now chemists at the Technische Universitaet Muenchen (TUM) have discovered two hitherto unknown mechanisms of action that can be used to permanently disarm an important bacterial protease.
Chemist gets U.S. patent for solution to antibiotic resistance problem (post with simple image)
A chemist based at the University of Copenhagen has just taken out a patent for a drug that can make previously multidrug-resistant bacteria once again responsive to antibiotics.
CAfGEN receives $3 million grant to study progression of TB and HIV (post with simple image)
The Consortium for African Genomics Network (CAfGEN), made up of University of Botswana, Makerere University, Baylor College of Medicine, Baylor Uganda Children’s Foundation and the Botswana-Baylor Children’s Clinical Centre of Excellence, has been awarded a $3.0 million three-year grant from the National Institutes of Health of the United States of America to study the genetic factors that affect the progression of TB and HIV in sub-Saharan Africa.
Novel vaccine trial design aims to answer key TB questions (post with simple image)
Prevention of infection study underway in South Africa.
CROI 2014: New drugs, novel combos top tuberculosis news at conference (post with simple image)
With increased TB activism and research into new treatments, preventive therapies, and diagnostics, the space devoted to TB at CROI has increased substantially.
Targeting a chink in TB bacteria’s armour (post with simple image)
A novel approach adopted by a team of researchers based in Bangalore has opened a window of opportunities to design new antimicrobials that could potentially be used to kill the tuberculosis-causing bacteria.
Novartis provides drug candidate compounds to TB Alliance (post with simple image)
Exclusive worldwide license from Novartis includes a novel class of drugs that is active against drug sensitive and multi-resistant strains of tuberculosis.
New vaccine shows promise as stronger weapon against both tuberculosis and leprosy (post with simple image)
UCLA-led research finds that a variant of an existing vaccine offers stronger protection against both diseases
PA-824 has a new generic name: pretomanid (post with simple image)
Pretomanid is a component of two new TB drug regimens being tested by TB Alliance for their ability to transform TB therapy, as well as future planned trials.
Page 70 of 74 · Total posts: 0
←First 69 70 71 Last→